“Exelixis Announces U.S. FDA Accepted the New Drug Application for Zanzalintinib in Combination with an Immune Checkpoint ...

The U.S. FDA has granted fast track status to pelareorep combination therapy for some KRAS-mutant, microsatellite-stable metastatic colorectal cancers.

When you add all types of colorectal cancer, that number soars past 150,000. And doctors are now seeing more young adults, under 50, diagnosed than ever before. But now there’s a new treatment that ...

The University of Wisconsin–Madison and Immuto Scientific have teamed up to explore new therapeutic targets in colorectal ...

A person walks past blue flags placed on the National Mall near the Capitol as part of an effort to advocate for funding and research into fighting colorectal cancer, Wednesday, March 12, 2025, in ...

Defining cure in stage II and III colon cancer has been challenging, and has never been systematically studied. In an analysis of 15 randomized trials, colon cancer relapse risk fell to 0.5% by year 6 ...

For years, a diagnosis of colon cancer meant potential surgery followed by a painful round of chemotherapy to kill the remaining cancer cells. One-size-fits-all treatment was normal. A new blood test ...

Cholera toxin shows promise against colon cancer by targeting tumors precisely while sparing healthy tissue, unlike brutal chemotherapy treatments.

Researchers note that toxin appeared to concentrate its effects within tumour tissue and did not cause any harmful inflammation in mice, such as effects on body weight, functions of vital organs and ...

FOX21's Loving Living Local speaks with leading experts and a colorectal cancer survivor about how biomarker testing is transforming care -helping doctors personalize treatment and improve outcomes.